Previous 10 | Next 10 |
AcelRx Announces Year-End 2020 Metrics and Review of 2020 Achievements PR Newswire REDWOOD CITY, Calif. , Jan. 14, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commerciali...
Marathon Patent Group MARA -19% after $250M capital raise.Zomedica (ZOM) -16%.Asia Pacific Wire & Cable Corporation (APWC) -16%.Harbor Custom Development HCDI -13% after pricing stock offering.Party City Holdco PRTY -12% after Q4 guidance falls short.Borr Dri...
Gainers: ArcLight Clean Transition (ACTCU) +80%.VOXX International (VOXX) +47%.BIOLASE (BIOL) +43%.Dolphin Entertainment (DLPN) +41%.ENGlobal (ENG) +39%.Zomedica (ZOM) +39%.IRIDEX (IRIX) +34%.AcelRx Pharmaceuticals (ACRX) +28%.La Jolla Pharmaceutical (LJPC) ...
AcelRx Pharmaceuticals ([[ACRX]] -4.3%) has entered into an agreement with three life sciences-focused investment funds that are existing investors and new investors in AcelRx, for the sale of 8,333,333 shares at $1.20 per share.Gross proceeds from the offering to be ~$10M. The closing of the...
AcelRx Pharmaceuticals Announces Publication of Clinical Data on Decreased Postoperative Opioid Requirements and Enhanced Postanesthesia Recovery Following Perioperative Use of DSUVIA® REDWOOD CITY, Calif. , Dec. 10, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals,...
AcelRx Announces $10 Million Registered Direct Common Stock Offering REDWOOD CITY, Calif. , Dec. 10, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of in...
AcelRx Pharmaceuticals to Present at LD Micro Main Event REDWOOD CITY, Calif. , Dec. 9, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for...
AcelRx Pharmaceuticals Announces Partnership with the National Rural Health Association REDWOOD CITY, Calif. , Dec. 4, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercializat...
AcelRx Pharmaceuticals Announces Commentary in Practical Pain Management on Previously Published Clinical Data on Preoperative Administration of DSUVIA® PR Newswire REDWOOD CITY, Calif., Nov. 18, 2020 REDWOOD CITY, Calif. , Nov. 18, 2020 /PRNewswire/ --&...
Acelrx shares plummeted after the company released third quarter earnings. However, numbers were significantly up compared to any prior period. A recently published study shows the excellent prospects of sublingual sufentanil. For further details see: AcelRx Pharmaceutic...
News, Short Squeeze, Breakout and More Instantly...
AcelRx Pharmaceuticals Inc. Company Name:
ACRX Stock Symbol:
NASDAQ Market:
AcelRx Pharmaceuticals Inc. Website:
AcelRx Announces Rebranding With Name Change to Talphera, Inc. PR Newswire Name change to "Talphera" reflects a new era of the Company in partnership with the medical community developing novel solutions for medically supervised settings Talphera will begin trading on ...
AcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States PR Newswire Use of CRRT increased during COVID and remained at these higher utilization levels Study results demonst...
AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update PR Newswire Niyad™ Investigational Device Exemption (IDE) approval by the FDA achieved in third quarter Company plans to begin its Niyad registrational study this quarter with topl...